14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARDS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Aridis Pharmaceuticals Inc. stock price ended at $0.0615 on Friday, after gaining 4.24%.
(Updated on May 03, 2024)

Sell candidate since Apr 11, 2024 Loss -16.30% PDF

The Aridis Pharmaceuticals Inc. stock price gained 4.24% on the last trading day (Friday, 3rd May 2024), rising from $0.0590 to $0.0615. During the last trading day the stock fluctuated 8.47% from a day low at $0.0590 to a day high of $0.0640. The price has risen in 5 of the last 10 days and is up by 2.5% over the past 2 weeks. Volume fell on the last day by -8 thousand shares and in total, 29 thousand shares were bought and sold for approximately $1.78 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.97% during the next 3 months and, with a 90% probability hold a price between $0.0480 and $0.0662 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARDS Signals & Forecast

There are mixed signals in the stock today. The Aridis Pharmaceuticals Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0695. On a fall, the stock will find some support from the short-term average at $0.0608. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 8.66%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Aridis Pharmaceuticals Inc. stock

Aridis Pharmaceuticals Inc. finds support from accumulated volume at $0.0600 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0050 between high and low, or 8.47%. For the last week the stock has had daily average volatility of 11.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARDS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Aridis Pharmaceuticals Inc. to open at $0.0615, and during the day (based on 14 day Average True Range), to move between $0.0546 and $0.0684, which gives a possible trading interval of +/-$0.0069 (+/-11.28%) up or down from last closing price. If Aridis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 22.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0615 (0.04%) than the support at $0.0600 (2.44%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aridis Pharmaceuticals Inc. stock A Buy?

Aridis Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.338 Sell Candidate Unchanged

Predicted Opening Price for Aridis Pharmaceuticals Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$0.0615 ( 0%) $0.0615

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARDS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0665 8.13 %
R2 0.0646 5.02 %
R1 0.0634 3.11 %
Current price: 0.0615
Support S1 0.0596 -3.11 %
S2 0.0584 -5.02 %
S3 0.0565 -8.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0750 21.95 %
R2 0.0706 14.72 %
R1 0.0615 0.0407 %
Current price 0.0615
Support S1 0.0600 -2.44%
S2 0.0590 -4.07%
S3 0.0588 -4.47%

FAQ

What is the symbol for Aridis Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Aridis Pharmaceuticals Inc. is ARDS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aridis Pharmaceuticals Inc. Stock?
Aridis Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Aridis Pharmaceuticals Inc. Stock?
Aridis Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aridis Pharmaceuticals Inc. Stock.

What's the current price of Aridis Pharmaceuticals Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Aridis Pharmaceuticals Inc. (ARDS) share was $0.0615.

What is the 52-week high and low for Aridis Pharmaceuticals Inc. Stock?
The 52-week high for Aridis Pharmaceuticals Inc. Stock is $0.540 and the 52-week low is $0.0500.

What is the market capitalization of Aridis Pharmaceuticals Inc. Stock?
As of the May 03, 2024, the market capitalization of Aridis Pharmaceuticals Inc. is 2.63M.

When is the next earnings date for Aridis Pharmaceuticals Inc.?
The upcoming earnings date for Aridis Pharmaceuticals Inc. is Jun 13, 2024.
Click to get the best stock tips daily for free!

About Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32... ARDS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT